REPORTING News & Analysis

Magellan is for the patient investor, says Morningstar's Shaun Ler.

We maintain our view current margin pressures are mostly temporary and leave our long-term estimates broadly unchanged.

Pay attention to half-yearly results but don't give them more weight than they deserve.

Both banks are sitting on billions in excess capital and dividends are expected to rise, says Morningstar equity analyst Nathan Zaia.

The societal upheaval wrought by the pandemic was positive for some sectors and dire for others.

Another week of ups and downs for Australia's largest listed companies.

The supermarket giant is trading on overly ambitious PE ratio, says Johannes Faul.

The wide-moat hearing implant maker was less affected by coronavirus elective surgery restrictions than analysts expected.

Earnings season heats up with mixed results from CBA, Telstra and Woodside Petroleum.

And its new suite of retail listed products should drive future funds under management, says Morningstar.